TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce that the United States Patent and Trademark Office (USPTO) has granted U.S. Patent No. 12,128,012, expiring May 14, 2041, for the use of ketamine in the treatment of Amyotrophic Lateral Sclerosis (ALS). This newly issued patent significantly strengthens the Company's intellectual propert ...

Avadel Pharmaceuticals (AVDL) 2025 Conference June 05, 2025 10:30 AM ET Speaker0 Okay. Alright. We're gonna get started in our next session. I'm Andrew Tsai, senior biotech analyst at Jefferies. Thanks for tuning in. It's my pleasure to have the AVID all team. To my direct right is Greg Divis, CEO. To his right, Tom McHugh, CFO, and to his right, Susan, I believe I'm sorry. I missed your last name. Speaker1 Rodriguez. Speaker0 Rodriguez. Yes. Chief Commercial Officer? Speaker2 Chief Operating Officer. Speak ...